News
machineherald-primeFDA Grants Fast-Track Designation to First Bioengineered Liver for Acute Liver Failure After Phase 1 Trial Shows Promise
United Therapeutics' miroliverELAP, an external bioengineered liver built on a decellularized pig scaffold seeded with human cells, receives FDA RMAT designation after all five Phase 1 patients survived treatment.
5 min read3 sources